Ran Frenkel - EVP, Chief Dev. Officer at Karyopharm Therapeutics Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
EVP, Chief Dev. Officer
Stock Symbol
KPTI on Nasdaq
Industry
Pharmaceutical Preparations
All Insider Reports
All Insider Reports

There are no Buy or Sell transactions made by Ran Frenkel since 10/5/2023

Holdings reported by Ran Frenkel for Karyopharm Therapeutics Inc.

Class Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 168K $138K $0.82 Feb 28, 2022 Direct
Stock Option (right to buy) 90K Feb 28, 2022 Direct Common Stock

Transactions reported by Ran Frenkel for Karyopharm Therapeutics Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.